Communication Strategies for Mechanically Ventilated Patients in Intensive Care Units

NCT05651984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-12-15

No results posted yet for this study

Summary

This prospective study consisted of (1) a descriptive cross-sectional part describing communication difficulties related to mechanical ventilation as experienced by intensive care professionals and patients, and (2) an experimental randomized crossover part comparing the use of a conventional low-tech communication board and a high-tech eye tracking technology-based device to improve communication effectiveness of intensive care mechanically ventilated patients.

Conditions

  • Mechanical Ventilation Complication
  • Communication, Nonverbal

Interventions

DEVICE

Comparison between communication board and eye tracking

The comparison between the communication board and eye tracking, conducted as a crossover, generates a randomization of the patients (from the cross-sectional part) into two groups and the communication interfaces were divided into two time periods: group A received eye tracking/communication board sequence and group B received communication board/eye tracking sequence.

Sponsors & Collaborators

  • CHU de Charleroi

    collaborator OTHER
  • University Hospital, Tours

    collaborator OTHER
  • University of Liege

    lead OTHER

Principal Investigators

  • Stephan Ehrmann, MD, PhD · University hospital and University of Tours

  • Laetitia Bodet-Contentin, MD, PhD · University hospital and University of Tours

  • Yoann Marechal, MD, PhD · University hospital of Charleroi

  • Emilie Szymkowicz, MSc · University of Liege

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-09
Primary Completion
2019-06-27
Completion
2019-06-27

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651984 on ClinicalTrials.gov